Latest Updates

Late last week the U.S. House passed by a 232 – 192 vote the “Affordable Insulin Now Act” (H.R. 6833), which would cap the monthly insulin copay for those with health insurance at $35 per month.

On March 24th, 2022, a bipartisan group of U.S. House Representatives introduced legislation, strongly supported by AmerisourceBergen (AB), Good Neighbor Pharmacy and the Future of Pharmacy Care Coalition (AB & GNP are Executive Committee members of the coalition), that would ensure patients continue to have access to essential pandemic and other health services provided by pharmacists, beyond the COVID-19 pandemic.

The AmerisourceBergen State Government Affairs team successfully opposed tax legislation in Washington and Hawaii which would have significantly burdened providers and patients and negatively impacted healthcare supply chain participants.

Jenni Zilka, President of Good Neighbor Pharmacy, recently had a letter to the editor published in the Washington Post, urging that pharmacists be provided the opportunity and means to successful carry out the program. Jenni’s letter to the editor calls for the FDA to amend the EUA for COVID-19 oral antivirals to give pharmacists the ability to prescribe and advocates for a permanent reimbursement infrastructure for clinical services provided by pharmacists in Medicare.

AmerisourceBergen continues to actively advocate for independent pharmacies regarding CMS’ 2023 proposed rule that affects patient copay outlays at the pharmacy counter.